drugset / Trial / NCT00648388
Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan's cilostazol 100 mg tablets and Otsuka's Pletal® 100 mg tablets following a single, oral 100 mg(1 x 100 mg) dose administered under fasting conditions.
Timeline
- Start
- 2004-03
- Primary completion
- 2004-05
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilostazol | Small molecule | 100 mg | Oral |
Indications
No indication recorded.